Navigation Links
Boston Scientific Completes Sale of Neurovascular Business
Date:1/3/2011

approvals, expected dilution, use of proceeds, clinical trials, product performance and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.  

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific to Present at 29th Annual J.P. Morgan Healthcare Conference
2. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
3. Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE® Patient Management System
4. EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino
5. SIGVARIS Provides Red Socks to Honor Efforts by Boston Red Sox Manager, Terry Francona, to Raise Awareness for DVT Prevention
6. PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston
7. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
8. Boston Scientific Completes Acquisition of Asthmatx
9. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
10. Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
11. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... October 31, 2014 Today, Analysts ... CELG ), Bristol-Myers Squibb Co. (NYSE: ... UNH ), Sanofi SA (NYSE: SNY ) ... these notes ahead of publication. To reserve complementary membership, ... ,-- ,Celgene Corporation Research Reports ,On October 23, 2014, ...
(Date:10/31/2014)... , Oct. 31, 2014  Zacks.com announces the list of ... Research analysts discuss the latest news and events impacting stocks and ... (Nasdaq: AMGN - Free Report ), Celgene (Nasdaq: ... BIIB - Free Report ), Market Vectors Biotech ... SPDR S&P Biotech ETF (AMEX: XBI - Free ...
(Date:10/31/2014)... , November 3, 2014 ... for men with BPH to discuss "male orgasmic dysfunction" ... shows ability to treat prostate symptoms while preserving sexual ... today welcomes the publication of a paper in the ... suffering from enlarged prostate to discuss with their doctors ...
Breaking Medicine Technology:Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
...  ViroPharma Incorporated (NASDAQ: VPHM ) today announced ... drug Plenadren ® (hydrocortisone, modified release tablet) were ... (JCEM), a leading scientific journal for endocrinology. Plenadren was ... insufficiency in adults. The authors described results ...
... SANTA MONICA, Calif., Feb. 16, 2012 GoodRx ... prescription drug price comparison technology that provides consumers with accurate ... both a website and free iphone app ... greatly between competing pharmacies, and find discounts, free coupons and ...
Cached Medicine Technology:Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 2Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 3Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 4Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 5Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 6GoodRx™ Brings Price Transparency to Prescription Drugs 2GoodRx™ Brings Price Transparency to Prescription Drugs 3GoodRx™ Brings Price Transparency to Prescription Drugs 4
(Date:11/1/2014)... 2014 On Saturday, November 15, 2014, ... walk at Hugh Taylor Birch State Park in Fort ... retinal diseases. According to the Foundation Fighting Blindness ... Usher syndrome are currently affecting more than 10 million ... , leading national retailer of assistive technology for the ...
(Date:11/1/2014)... Haelle HealthDay Reporter FRIDAY, ... adult anger and alter their behavior in response to it, ... co-author Andrew Meltzoff, co-director of the University of Washington Institute ... only from their own direct social experiences but from watching ... he was most surprised at how emotionally "sophisticated" the babies ...
(Date:10/31/2014)... Branch, TX (PRWEB) October 31, 2014 ... in preparation for winter. Many quality electric space heaters ... is stocking the superior Broan-Nutone Big Heat 1500w portable ... which is newly available at TheHardwareCity.com, offers an energy ... house or cabin. The ceramic heating elements produce 1500 ...
(Date:10/31/2014)... The process of cell division is central to life. ... each other, has fascinated scientists since the dawn of ... long, it has been notoriously difficult to study this ... before cleaving in two. , The name given to ... "cell movement" and captures the sense of a highly ...
(Date:10/31/2014)... In the first study of its kind, Rice University ... circuits that cause cancer cells to become metastatic. The ... allows cancer cells to both migrate and form new ... to new drugs that interfere with the genetic switches ... cells and circulating tumor cells -- two of the ...
Breaking Medicine News(10 mins):Health News:Lesa Kretschmer, CEO of Florida Reading & Vision Technology, Inc. Named Event Chair of the Foundation Fighting Blindness 2014 South Florida VisionWalk 2Health News:Lesa Kretschmer, CEO of Florida Reading & Vision Technology, Inc. Named Event Chair of the Foundation Fighting Blindness 2014 South Florida VisionWalk 3Health News:Study Shows How Toddlers Adjust to Adult Anger 2Health News:Study Shows How Toddlers Adjust to Adult Anger 3Health News:Big Heat 1500w Electric Space Heater Now Available at TheHardwareCity.com 2Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3
... have a choice when it comes to their bowel cancer ... to the launch// of the first Australian national bowel cancer ... and harms of alternate screening methods, the Government decided not ... ,Eligible people turning 55 or 65 this year will be ...
... that experimental dietary regimens can calm and even ... which appears in the July 2006 issue of ... to show that restricting caloric intake, specifically carbohydrates, ... brain associated with longevity. ,“Both clinical and ...
... Consultants Association which recently appointed a new president has ... mind among consultants//. ,Dr Mary Mc Caffrey, ... "There is nothing to be gained by a consultant ... staff are not also present. The reforms we need ...
... British baby who was born blind was successfully operated//. ... second youngest child in the world to undergo the surgery. He ... the surgery in the New York State. , James ... surgery on the kid said that there were no complications. ...
... evidence of the consistent ingenuity displayed by China, has ... have also devised a new technology that will help ... by the Ministry of Agriculture. National Avian Influenza Reference ... ,The ministry is hopeful of the powerful defensive mechanism ...
... American Medical Association has backed a tax penalty for uninsured ... not to//. This number has been estimated to be about ... already been considering legislation towards this issue in Congress and ... voting in favor of individual responsibility comes close on its ...
Cached Medicine News:Health News:Choosing your Bowel Cancer Test 2Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 2Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 3Health News:AMA Supports Tax Penalty for Uninsured Americans 2
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
... Vitrasert implant is a device that ... Aids-related Cytomegalovirus (CMV) Retinitis. This approach ... when compared with conventional intravenous treatment. ... in a polymer-based system that slowly ...
Near PT test card/illus of the ocular adnexa 5 1/2" X 8"....
Medicine Products: